✦ LIBER ✦

Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel

✍ Scribed by Michael Millward, Paul Mainwaring, Alain Mita, Kristine Federico, G. K. Lloyd, Natasha Reddinger, Steffan Nawrocki, Monica Mita, Matthew A. Spear

Book ID: 113064495
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 274 KB
Volume: 30
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-011-9642-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

42 POSTER NPI-2358 (a novel vascular dis

42 POSTER NPI-2358 (a novel vascular disrupting agent) Phase 1 dose escalation trial with an RP2D cohort

✍ M. Mita; M.A. Spear; L.K. Yee; K.P. Papadopoulos; E.I. Heath; M. Pilat; O. Romer 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 65 KB

450 POSTER NPI-2358, a novel tumor vascu

450 POSTER NPI-2358, a novel tumor vascular disrupting agent potentiates the anti-tumor activity of docetaxel in the non small cell lung cancer model MV522

✍ S. Neuteboom; E. Medina; M.A. Palladino; M.A. Spear; G.K. Lloyd; S. Nawrocki 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 64 KB

1236 Assessment of pharmacodynamic effec

1236 Assessment of pharmacodynamic effect in a Phase I study of NPI-2358, an IV administered vascular disruptive agent, using dynamic contrast-enhanced MRI

✍ E. Ashton; K. Lloyd; M. Spear 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

A phase I pharmacokinetic study of the v

A phase I pharmacokinetic study of the vascular disrupting agent ombrabulin (AVE8062) and docetaxel in advanced solid tumours

✍ Eskens, F A L M; Tresca, P; Tosi, D; Van Doorn, L; Fontaine, H; Van der Gaast, A 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 322 KB

386 Phase I study of the vascular disrup

386 Phase I study of the vascular disrupting agent (VDA) ombrabulin (Ob) in combination with taxanes (T) and platinum salts (PS) in patients (pts) with advanced solid tumors

✍ J.C. Soria; R. Bahleda; B. Besse; C. Sessa; R.g. Calderone; L. Gianni; G. Del Co 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Evaluation of the safety and pharmacodyn

Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers

✍ Stead, R. B. 📂 Article 📅 2006 🏛 American Society of Hematology 🌐 English ⚖ 270 KB